Methylene Blue has a potent antiviral activity against SARS-CoV-2 and H1N1 influenza virus in the absence of UV-activation in vitro

Autor: Caroline Tapparel, Thomas Cerny, Chiara Medaglia, Andreas Cerny, Erich H Cerny, Valeria Cagno, Arnaud Charles-Antoine Zwygart

Publikováno v: Scientific Reports, Vol. 11, No 1 (2021) P. 14295
Scientific reports, vol. 11, no. 1, pp. 14295
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Scientific Reports

Methylene blue is an FDA (Food and Drug Administration) and EMA (European Medicines Agency) approved drug with an excellent safety profile. It displays broad-spectrum virucidal activity in the presence of UV light and has been shown to be effective i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6020a29ad34beedd3ef3bc09748b0f69
https://archive-ouverte.unige.ch/unige:154384